Fidelity Investments’s Applied Therapeutics APLT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-184
| Closed | -$18 | – | 5420 |
|
|
2025
Q4 | $18 | Sell |
184
-17,298
| -99% | -$11K | ﹤0.01% | 5361 |
|
|
2025
Q3 | $10.6K | Sell |
17,482
-349
| -2% | -$164 | ﹤0.01% | 4594 |
|
|
2025
Q2 | $5.55K | Sell |
17,831
-52,133
| -75% | -$20.2K | ﹤0.01% | 4689 |
|
|
2025
Q1 | $34.2K | Sell |
69,964
-106,072
| -60% | -$62.5K | ﹤0.01% | 4025 |
|
|
2024
Q4 | $151K | Buy |
176,036
+173,635
| +7,232% | +$1.09M | ﹤0.01% | 3377 |
|
|
2024
Q3 | $20.4K | Buy |
2,401
+1,301
| +118% | +$7.67K | ﹤0.01% | 4165 |
|
|
2024
Q2 | $5.14K | Buy |
+1,100
| New | +$5.21K | ﹤0.01% | 4545 |
|
|
2024
Q1 | – | Sell |
-2,427,436
| Closed | -$8.13M | – | 5349 |
|
|
2023
Q4 | $8.13M | Sell |
2,427,436
-212,100
| -8% | -$528K | ﹤0.01% | 1921 |
|
|
2023
Q3 | $6.57M | Hold |
2,639,536
| – | – | ﹤0.01% | 1958 |
|
|
2023
Q2 | $3.38M | Sell |
2,639,536
-332,835
| -11% | -$442K | ﹤0.01% | 2170 |
|
|
2023
Q1 | $2.41M | Hold |
2,972,371
| – | – | ﹤0.01% | 2323 |
|
|
2022
Q4 | $2.26M | Sell |
2,972,371
-231,600
| -7% | -$183K | ﹤0.01% | 2340 |
|
|
2022
Q3 | $2.98M | Sell |
3,203,971
-803,312
| -20% | -$964K | ﹤0.01% | 2316 |
|
|
2022
Q2 | $3.8M | Buy |
4,007,283
+3,103,990
| +344% | +$5.08M | ﹤0.01% | 2322 |
|
|
2022
Q1 | $1.91M | Sell |
903,293
-1,340,183
| -60% | -$3.59M | ﹤0.01% | 2624 |
|
|
2021
Q4 | $20.1M | Sell |
2,243,476
-166,771
| -7% | -$2.19M | ﹤0.01% | 1821 |
|
|
2021
Q3 | $40M | Sell |
2,410,247
-9,593
| -0.4% | -$166K | ﹤0.01% | 1513 |
|
|
2021
Q2 | $50.3M | Sell |
2,419,840
-113,226
| -4% | -$2.14M | ﹤0.01% | 1427 |
|
|
2021
Q1 | $47.5M | Buy |
2,533,066
+309,101
| +14% | +$6.67M | ﹤0.01% | 1428 |
|
|
2020
Q4 | $48.9M | Sell |
2,223,965
-110,452
| -5% | -$2.3M | ﹤0.01% | 1332 |
|
|
2020
Q3 | $48.5M | Buy |
2,334,417
+378,236
| +19% | +$9.83M | ﹤0.01% | 1206 |
|
|
2020
Q2 | $70.7M | Buy |
1,956,181
+768,765
| +65% | +$32.2M | 0.01% | 1025 |
|
|
2020
Q1 | $38.8M | Buy |
1,187,416
+906,486
| +323% | +$36.7M | 0.01% | 1126 |
|
|
2019
Q4 | $7.66M | Sell |
280,930
-305,200
| -52% | -$5.23M | ﹤0.01% | 1936 |
|
|
2019
Q3 | $6.44M | Hold |
586,130
| – | – | ﹤0.01% | 1973 |
|
|
2019
Q2 | $4.83M | Buy |
+586,130
| New | +$5.55M | ﹤0.01% | 2099 |
|
Fidelity Investments's APLT Position: Q1 2026 in Review
Fidelity Investments sold out of Applied Therapeutics (APLT) in Q1 2026, closing a stake of 184 shares — an estimated $18 sold.
Fidelity Investments first reported a position in APLT in Q2 2019 and held it in 26 quarters. The position peaked at $70.7M in Q2 2020. 0 funds tracked by Wall St. Rank hold APLT as of Q1 2026.
- Fidelity Investments reported no remaining Applied Therapeutics position as of Q1 2026 after selling out during the quarter.
- Fidelity Investments sold 184 Applied Therapeutics shares in Q1 2026, an estimated $18.
- Fidelity Investments first reported a position in Applied Therapeutics in Q2 2019 and held it in 26 quarters.
- Fidelity Investments's Applied Therapeutics position peaked at $70.7M in Q2 2020.
- 0 funds tracked by Wall St. Rank held Applied Therapeutics as of Q1 2026.
Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.